Infinium Pharmachem (NSE:INFINIUM) Total Long-Term Assets: ₹649 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:INFINIUM Infinium Pharmachem Ltd NSE:INFINIUM
85 GF Score
Price ₹271.20
GF Value ₹310.08
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Infinium Pharmachem Total Long-Term Assets?

Infinium Pharmachem NSE:INFINIUM +2.73% 85 Total Long-Term Assets is ₹649 Mil as of Mar. 2026. GuruFocus rates NSE:INFINIUM with a GF Score™ of 85/100 and a GF Value™ of ₹310.08 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Infinium Pharmachem's Total Long-Term Assets for the quarter that ended in Mar. 2026 was ₹649 Mil.

Infinium Pharmachem Total Long-Term Assets Related Terms

Infinium Pharmachem Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for Infinium Pharmachem's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Infinium Pharmachem Total Long-Term Assets Chart

Infinium Pharmachem Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Long-Term Assets
Get a 7-Day Free Trial 153.15 192.99 204.42 584.69 649.38

Infinium Pharmachem Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 204.42 641.91 584.69 595.65 649.38
NSE:INFINIUM
85GF Score
Infinium Pharmachem Ltd NSE:INFINIUM
Total Long-Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Infinium Pharmachem Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →
What does a Total Long-Term Assets of ₹649 Mil mean?
Infinium Pharmachem (NSE:INFINIUM) has a Total Long-Term Assets of ₹649 Mil as of Mar. 2026. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Infinium Pharmachem and its competitors.
Is Infinium Pharmachem's Total Long-Term Assets too high?
Infinium Pharmachem's current Total Long-Term Assets is ₹649 Mil. Overall, Infinium Pharmachem has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Infinium Pharmachem's Total Long-Term Assets compare to DOW?
Infinium Pharmachem's Total Long-Term Assets of ₹649 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Assets for a Chemicals company?
A good Total Long-Term Assets depends on the Chemicals industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Assets mean?
A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Infinium Pharmachem and its competitors. Infinium Pharmachem's current Total Long-Term Assets is ₹649 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Infinium Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Infinium Pharmachem (NSE:INFINIUM) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹310.08, compared to a current price of ₹271.20 — trading 12.5% below its estimated fair value. The current Total Long-Term Assets is ₹649 Mil. Infinium Pharmachem's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Assets calculated?
Total Long-Term Assets is calculated from a company's financial statements. For Infinium Pharmachem (NSE:INFINIUM), the current Total Long-Term Assets is ₹649 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Infinium Pharmachem (NSE:INFINIUM) Overvalued in 2026?

Based on GuruFocus' analysis, Infinium Pharmachem stock appears to be undervalued. The current stock price of ₹271.20 is trading 12.5% below its estimated GF Value™ of ₹310.08. GuruFocus considers Infinium Pharmachem to be Modestly Undervalued.

Key valuation signals for NSE:INFINIUM:

  • Total Long-Term Assets: ₹649 Mil
  • GF Value™: ₹310.08 vs. price of ₹271.20 (12.5% below fair value)
  • GF Score™: 85/100 with 2 warning signs

No single metric tells the full story. See the NSE:INFINIUM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Infinium Pharmachem Business Description

Address V.U. Nagar GIDC Road, Near Sardar Patel Statue, Suite 205, Sigma Prime, 2nd Floor, District Anand, Vallabh Vidhyanagar, GJ, IND, 388120
Infinium Pharmachem Ltd is engaged in the business of manufacturing and supplying Iodine, Iodine Derivatives and Active Pharmaceutical Ingredients (APIs). It provides fully integrated customized services from R & D to Commercial scale manufacturing and packaging for its products to the Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals and various other chemicals Industries.
85GF Score

Get the complete analysis for NSE:INFINIUM

Total Long-Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹271.20
Price
₹310.08
GF Value